Siren »

ADC Therapeutics SA shares owned by Siren

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Siren from 13F filings

Historical chart of Siren investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.7M 1.2M 3.15

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding ADC Therapeutics SA

Redmile Group
OrbiMed Advisors
BlackRock
BlackRock
Morgan Stanley
Bank of America Corporation
Silverarc Capital Management
Goldman Sachs Group
Platinum Investment Mangement
Siren
State Street Corporation
Geode Capital Management
Vantage Consulting Group
Blue Owl Capital Holdings
Sphera Funds Management

View all funds holding ADC Therapeutics SA